AstraZeneca
ACIP Recommends Beyfortus to Prevent RSV in Infants
The CDC’s Advisory Committee on Immunization Practices voted unanimously for universal use of nirsevimab ...
AUGUST 3, 2023
Beyfortus Approved to Prevent RSV in Infants & Children
The FDA approved Beyfortus (for the prevention of RSV lower respiratory tract disease in newborns and infants born ...
JULY 17, 2023
Concerns of Evusheld Lacking Protection Against Omicron XBB.1.5
The FDA does not expect Evusheld (AstraZeneca) to have the ability to neutralize XBB.1.5, a new emerging Omicron ...
JANUARY 9, 2023
FluMist Recommended for Next Influenza Season
The ACIP says that FluMist can be used again for the 2018-2019 influenza season. Concerns over efficacy resolved.
FEBRUARY 22, 2018
Load more